Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Clinical Trial Results
Biotech
Avidity's latest DMD data drop assuages safety concerns: analyst
After some earlier data sparked questions from analysts, Avidity has released more data for its RNA-based Duchenne muscular dystrophy candidate.
Darren Incorvaia
Mar 17, 2025 2:00pm
Emalex eyes potential Tourette approval after phase 3 win
Feb 25, 2025 1:18pm
Denali rare disease drug clears safety study, reduces biomarkers
Feb 6, 2025 12:05pm
Radioisotope manufacturer ITM grabs spotlight with phase 3 win
Jan 28, 2025 5:00am
Lilly's next obesity drug just cut an average of 58 pounds
Jun 26, 2023 8:45pm
Aldeyra's dry eye disease drug scores phase 3 conjunctivitis win
Jun 15, 2023 9:30am
